Effect of propranolol, practolol and atenolol on human platelet thromboxane formation and plasma levels of prostaglandins 6-KETO-F 1lα and E2
- 30 November 1984
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes and Medicine
- Vol. 16 (2) , 191-203
- https://doi.org/10.1016/0262-1746(84)90071-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- ANTI-PLATELET ACTIVITY OF BETA-ADRENERGIC ANTAGONISTS: INHIBITION OF THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION IN PATIENTS RECEIVING LONG-TERM PROPRANOLOL TREATMENTThe Lancet, 1981
- Thromboxane A2 and prostaglandin H2: Potent stimulators of the swine coronary arteryProstaglandins, 1976
- Reversal of Abnormal Platelet Aggregability and Change in Exercise Tolerance in Patients with Angina Pectoris Following Oral PropranololCirculation, 1974
- Platelet Function Studies in Coronary Artery DiseaseCirculation, 1973
- Inhibition by antiarrhythmic and ?-sympatholytic drugs of serotonin uptake by human platelets: Experimentsin vitro andin vivoEuropean Journal of Clinical Pharmacology, 1973
- Platelet studies in patients with coronary artery disease and in their relatives.Heart, 1972
- The effect of various beta-receptor blocking agents on platelet aggregationCellular and Molecular Life Sciences, 1969
- Studies on the Effect of Adrenergic Blocking Drugs on Catecholamine‐Induced Platelet Aggregation and Uptake of Noradrenaline and 5‐HydroxytryptamineActa Physiologica Scandinavica, 1969
- Increased platelet adhesiveness in hypertensive cardiovascular diseaseJournal of Atherosclerosis Research, 1968
- Coagulation Tests and Platelet Economy in Atherosclerotic and Control SubjectsCirculation, 1962